| 2024-05-29 | Genelux Corporation GNLX | director | 6,250 0.0264% | $4.00 | $25,000 | -14.64% | ||
| 2023-09-13 | Sale | Genelux Corporation GNLX | director | 900 0.0032% | $20.78 | $18,702 | -54.7% | |
| 2021-03-10 | Sale | Arcutis Biotherapeutics, Inc. ARQT | Chief Financial Officer | 3,500 0.0065% | $28.44 | $99,540 | -31.06% | |
| 2021-03-01 | Sale | Arcutis Biotherapeutics, Inc. ARQT | Chief Financial Officer | 1,546 0.0032% | $34.20 | $52,879 | -35.34% | |
| 2021-02-10 | Sale | Arcutis Biotherapeutics, Inc. ARQT | Chief Financial Officer | 5,500 0.01% | $31.01 | $170,550 | -35.64% | |
| 2021-02-01 | Sale | Arcutis Biotherapeutics, Inc. ARQT | Chief Financial Officer | 10,000 0.0183% | $30.84 | $308,351 | -32.97% | |
| 2021-01-19 | Sale | Arcutis Biotherapeutics, Inc. ARQT | Chief Financial Officer | 3,500 0.0067% | $25.95 | $90,840 | -13.27% | |
| 2020-12-14 | Sale | Arcutis Biotherapeutics, Inc. ARQT | Chief Financial Officer | 10,500 0.0198% | $25.95 | $272,521 | -9.59% | |
| 2020-09-29 | Sale | Arcutis Biotherapeutics, Inc. ARQT | Chief Financial Officer | 3,500 0.0078% | $25.95 | $90,840 | -14.19% |